These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 1964232
21. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells. Chetty R. Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398 [Abstract] [Full Text] [Related]
22. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up]. Nagai S, Chiba W, Ikeda S, Matsumoto H, Fujimoto T, Ishida H, Wazawa H, Hanawa T, Yamashita N, Yasuda Y, Matsubara Y, Hatakenaka R, Funatsu T. Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555 [Abstract] [Full Text] [Related]
23. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer]. Li R, Li R, Wang Y. Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296 [Abstract] [Full Text] [Related]
24. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker. Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T. Anticancer Res; 2000 Jan; 20(2B):1311-6. PubMed ID: 10810441 [Abstract] [Full Text] [Related]
25. [Analysis of cellular DNA-RNA content using flow cytometry between primary and metastatic foci in lung carcinoma]. Yamaoka N, Tagawa Y, Ayabe H, Kawahara K, Kida H, Uchiyama T, Tomita M. Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):901-6. PubMed ID: 2169021 [Abstract] [Full Text] [Related]
26. Prognostic significance of flow cytometry in non-small-cell lung cancer. Rice TW, Bauer TW, Gephardt GN, Medendorp SV, McLain DA, Kirby TJ. J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505 [Abstract] [Full Text] [Related]
28. Proteomic signatures for histological types of lung cancer. Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S. Proteomics; 2005 Jul; 5(11):2939-48. PubMed ID: 15996008 [Abstract] [Full Text] [Related]
29. The implications of proliferation and apoptosis for lung cancer metastasis. Volm M, Koomagi R. Oncol Rep; 1999 Jul; 6(2):373-6. PubMed ID: 10023008 [Abstract] [Full Text] [Related]
30. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer. Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F. Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189 [Abstract] [Full Text] [Related]
31. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways. Leers MP, Theunissen PH, Koudstaal J, Schutte B, Ramaekers FC. Cytometry; 1997 Feb 01; 27(2):179-88. PubMed ID: 9012385 [Abstract] [Full Text] [Related]
32. Combined morphometrical and syntactic structure analysis as tools for histomorphological insight into human lung carcinoma growth. Kayser K, Stute H, Bubenzer J, Paul J. Anal Cell Pathol; 1990 Apr 01; 2(3):167-78. PubMed ID: 2177350 [Abstract] [Full Text] [Related]
33. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Zheng H, Tsuneyama K, Takahashi H, Miwa S, Nomoto K, Saito H, Masuda S, Takano Y. Anticancer Res; 2007 Apr 01; 27(1B):575-81. PubMed ID: 17348444 [Abstract] [Full Text] [Related]
34. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep 01; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
35. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage. Juczewska M, Chyczewski L, Telego M, Chyczewska E, Nikliński J, Tańska M, Laudański J. Rocz Akad Med Bialymst; 1997 Sep 01; 42 Suppl 1():254-70. PubMed ID: 9337543 [Abstract] [Full Text] [Related]
36. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Simony J, Pujol JL, Radal M, Ursule E, Michel FB, Pujol H. Cancer Res; 1990 Jul 15; 50(14):4382-7. PubMed ID: 2163748 [Abstract] [Full Text] [Related]
37. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas. Dobashi Y, Watanabe H, Sato Y, Hirashima S, Yanagawa T, Matsubara H, Ooi A. J Pathol; 2006 Dec 15; 210(4):431-40. PubMed ID: 17029220 [Abstract] [Full Text] [Related]
38. Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country: experience of a university teaching hospital. Liam CK, Pang YK, Leow CH, Poosparajah S, Menon A. Lung Cancer; 2006 Jul 15; 53(1):23-30. PubMed ID: 16690159 [Abstract] [Full Text] [Related]
39. [Comparative histo- and cytospectrophotometric study of the DNA content in the nuclei of lung cancer cells]. Krysteva-Sedmakova LTs. Arkh Patol; 1980 Jul 15; 42(11):28-35. PubMed ID: 6255908 [Abstract] [Full Text] [Related]
40. An autopsy study of lung cancer with special reference to the relationship between cigarette smoking and histological differentiation of adenocarcinoma and squamous cell carcinoma. Morita T, Urano Y. Jpn J Clin Oncol; 1989 Jun 15; 19(2):94-101. PubMed ID: 2733176 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]